切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2022, Vol. 18 ›› Issue (04) : 460 -467. doi: 10.3877/cma.j.issn.1673-5250.2022.04.012

论著

实验室指标在早期鉴别诊断脓毒症和川崎病中的应用
陈丽妮, 乔莉娜()   
  1. 四川大学华西第二医院儿童重症监护室、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2022-01-18 修回日期:2022-07-01 出版日期:2022-08-01
  • 通信作者: 乔莉娜

Laboratory indicators in the early differential diagnosis of sepsis and Kawasaki disease

Lini Chen, Lina Qiao()   

  1. Pediatric Intensive Care Unit, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2022-01-18 Revised:2022-07-01 Published:2022-08-01
  • Corresponding author: Lina Qiao
  • Supported by:
    Project of Sichuan Academic and Technology Leadership Training Support([2017]919-23); Sichuan Science and Technology Plan Project(2019YFS0245)
引用本文:

陈丽妮, 乔莉娜. 实验室指标在早期鉴别诊断脓毒症和川崎病中的应用[J/OL]. 中华妇幼临床医学杂志(电子版), 2022, 18(04): 460-467.

Lini Chen, Lina Qiao. Laboratory indicators in the early differential diagnosis of sepsis and Kawasaki disease[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2022, 18(04): 460-467.

目的

探讨早期鉴别诊断脓毒症与川崎病的生物标志物。

方法

选择2017年1月1日至2018年2月28日,于四川大学华西第二医院出院时确诊为脓毒症及川崎病的患儿为研究对象,并分别纳入脓毒症组(n=286)和川崎病组(n=326)。采用Mann-Whitney U秩和检验对2组患儿的白细胞计数(WBC)、中性粒细胞百分比、中性粒细胞绝对计数(ANC)、C反应蛋白(CRP)、血小板计数(PLT)、血红蛋白(Hb),红细胞沉降率(ESR)、降钙素原(PCT)、血小板平均体积(MPV)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT),天冬氨酸氨基转移酶(AST)、丙氨酸转移酶(ALT)、乳酸脱氢酶(LDH)、白蛋白、血尿素氮(BUN)、血清肌酐(SCr)、D-二聚体(DD)、纤维蛋白原降解物(FDP)、国际正常化比率(INR)、肌钙蛋白I(cTnI)、肌红蛋白(Mb)、N端脑钠肽(NTBNP)、纤维蛋白原(Fg),动脉血氧分压(PaO2)、吸入氧气分数(FiO2)、Na、K、Ca2+、Cl等指标进行统计学分析。采用χ2检验或连续性校正χ2检验对2组患儿病死率、冠状动脉扩张发生率等进行统计学分析。2组患儿的性别构成比比较,差异无统计学意义(P>0.05)。本研究遵循的程序符合2013年修订的《世界医学协会赫尔辛基宣言》的要求。

结果

①脓毒症组患儿年龄小于川崎病组,入院前发热时间短于川崎病组,2组比较,差异均有统计学意义(P<0.05)。②脓毒症组患儿PCT水平高于川崎病组,而中性粒细胞百分比、ANC和ESR水平低于川崎病组,2组分别比较,差异均有统计学意义(P<0.05)。此外,脓毒症组患儿PCT值>0.5 ng/mL及PCT值>2 ng/mL者占比,均高于川崎病组,而CRP水平>30 mg/L、ESR>40 mm/h者占比,均低于川崎病组,2组分别比较,差异均有统计学意义(P<0.05)。③脓毒症组患儿的MPV、AST、LDH、BUN、SCr、Cl、DD、FDP、cTnI、Mb水平,均高于川崎病组,而Hb、PLT、ALT、Fg水平,均低于川崎病组,并且差异亦均有统计学意义(P<0.05)。④2组患儿呼吸系统功能损伤、循环系统功能损伤、消化系统功能损伤、泌尿系统功能损伤、凝血功能异常、血电解质异常、贫血及血小板增多者所占比例比较,差异均有统计学意义(P<0.05)。⑤脓毒症组与川崎病组住院期间患儿死亡率分别为5.2%(15例)与0,并且差异有统计学意义(χ2=17.527,P<0.001)。

结论

儿童脓毒症和川崎病在早期难以鉴别,易被误诊和漏诊。二者虽然很多实验室检查结果类似,但亦有部分实验室结果存在差异。脓毒症患儿的脏器损伤更严重、预后更差。

Objective

To explore biomarkers for early differential diagnosis of sepsis and Kawasaki disease.

Methods

Children diagnosed with sepsis and Kawasaki disease at the discharge from West China Second Hospital, Sichuan University from January 1, 2017 to February 28, 2018 were selected into this study, and they were included into sepsis group (n=286) and Kawasaki disease group (n=326), respectively. The levels of white blood cell count (WBC), absolute neutrophil count (ANC), C-reactive protein (CRP), platelet count (PLT), erythrocyte sedimentation rate (ESR), hemoglobin (Hb), mean platelet volume (MPV), aspartate aminotransferase (AST), alanine transferase (ALT), lactate dehydrogenase (LDH), blood urea nitrogen (BUN), serum creatinine (SCr), D-dimer (DD), fibrinogen degradation (FDP), troponin I (cTnI), myoglobin (Mb), hemoglobin (Hb), fibrinogen (Fg), partial pressure of oxygen in artery (PaO2), fraction of inspired oxygen (FiO2), activated partial thromboplastin time (APTT), international normalized ratio (INR), and other laboratory indexes between two groups were statistically analyzed by Mann-Whitney U rank sum test. The mortality and the incidence of coronary artery dilatation between two groups were statistically analyzed by chi-square test, continuity correction of chi-square test. There was no significant difference in gender ratio between two groups (P>0.05). This study was in line with the World Medical Association Declaration of Helsinki revised in 2013.

Results

The age of children in sepsis group was younger than that in Kawasaki disease group, but the fever duration before admission in sepsis group was shorter than that in Kawasaki disease group, and the differences between two groups were statistically significant (P<0.05). ②The PCT level in sepsis group was higher than that in Kawasaki disease group, but the percentage of neutrophils, ANC and ESR levels were lower than those in Kawasaki disease group, and the differences between two groups were statistically significant (P<0.05). In addition, in sepsis group, the proportion of PCT value >0.5 ng/mL and PCT value >2 ng/mL were higher than those of Kawasaki disease group, while the proportion of CRP level >30 mg/L and ESR >40 mm/h were lower than those of Kawasaki disease group, and the difference between two groups in terms of above indexes were statistically significant (P<0.05). ③The levels of MPV, AST, LDH, BUN, SCr, Cl-, DD, FDP, cTnI and Mb in sepsis group were higher than those in Kawasaki disease group (P<0.05). In addition, the levels of Hb, PLT, ALT and Fg in sepsis group were lower than those in Kawasaki disease group, and the differences between groups were statistically significant (P<0.05). ④There were significant differences in the proportion of respiratory system dysfunction, circulatory system dysfunction, digestive system dysfunction, urinary system dysfunction, coagulation dysfunction, blood electrolyte abnormality, anemia and thrombocytosis between two groups (P<0.05). ⑤The mortality rates of children in sepsis group and Kawasaki disease group were 5.2% (15 cases) and 0, respectively, and the difference was statistically significant (χ2=17.527, P<0.001).

Conclusions

Childhood sepsis and Kawasaki disease are difficult to differentiate in the early stages and are easily misdiagnosed. Although many laboratory results are similar, there are some differences between the two. In children with sepsis, the organ damage is more severe and the prognosis is worse.

表1 2组患儿一般临床资料比较[M(Q1Q3)]
表2 2组患儿入院时炎症指标比较
表3 脓毒症组与川崎病组其他实验室检查指标比较[M(Q1Q3)]
组别 例数 Hb(g/L) PLT(×109/L) MPV(fL) ALT(U/L) AST(U/L) 白蛋白((g/L)
脓毒症组 286 107.0(93.0,115.0) 287.0(197.0,396.2) 9.7(9.0,10.6) 35.0(27.0,48.0) 38.0(31.0,54.0) 37.3(32.5,40.6)
川崎病组 326 110.0(103.0,116.0) 321.5(274.0,395.0) 9.4(8.9,10.1) 40.0(27.0,86.5) 34.0(28.0,53.3) 37.3(34.1,40.8)
Z   -3.727 -3.977 -2.597 -2.503 -2.838 -0.699
P   <0.001 <0.001 0.009 0.012 0.005 0.484
组别 例数 TB(μmol/L) IBIL(μmol/L) LDH(U/L) SCr(μmol/L) BUN(mmol/L) Na(mmol/L)
脓毒症组 286 4.8(2.6,8.3) 4.3(2.4,7.8) 602.0(494.0,815.0) 31.0(26.0,40.0) 3.2(2.2,4.5) 135.8(132.9,138.0)
川崎病组 326 4.9(3.1,7.7) 4.2(2.5,6.1) 515.0(360.0,636.0) 29.0(25.0,34.0) 2.6(2.0,3.3) 136.0(133.4,138.6)
Z   -0.444 -1.443 -6.530 -3.048 -4.715 -1.655
P   0.657 0.149 <0.001 0.002 <0.001 0.098
组别 例数 K(mmol/L) Cl(mmol/L) Ca2+(mmol/L) 血糖(mmol/L) Fg(mg/dL) DD(mg/L)
脓毒症组 286 4.1(3.7,4.5) 102.4(99.2,105.0) 2.3(2.1,2.4) 5.7(4.9,6.4) 391.0(257.0,570.0) 2.3(0.8,4.4)
川崎病组 326 4.1(3.6,4.4) 100.6(97.8,103.0) 2.3(2.2,2.4) 5.5(4.8,6.2) 570.0(455.0,644.0) 1.4(0.9,2.6)
Z   -1.408 -4.649 -0.321 -1.699 -7.021 -2.037
P   0.159 <0.001 0.749 0.089 <0.001 0.042
组别 例数 FDP(μg/L) NTBNP(pg/mL) cTnI(μg/L) Mb(μg/L) 乳酸(mmol/L)
脓毒症组 286 8.7(4.9,17.1) 1 180.0(424.0,3 740.0) 0.012(0.012,0.017) 24.9(16.4,72.9) 1.7(1.2,2.6)
川崎病组 326 7.0(4.4,12.0) 1 010.0(387.0,3 070.0) 0.012(0.012,0.012) 16.2(12.4,25.6) 1.3(1.0,1.6)
Z   -2.283 -0.545 -3.697 -6.131 -1.954
P   0.022 0.586 <0.001 <0.001 0.051
表4 2组患儿影像学及尿常规检查结果比较[%(n/n′)]
表5 2组判断患儿脏器功能损伤情况指标的发生率比较[%(n/n′)]
组别 例数 循环系统功能损伤 消化系统功能损伤
乳酸>2 mmol/L cTnI>0.034 μg/L NTBNP>450 pg/mL AST>基线2倍 ALT>基线2倍 TB>70 μmol/L 白蛋白<30 g/L
脓毒症组 286 38.3(41/107) 18.8(29/154) 73.7(73/99) 10.8(30/279) 7.5(21/279) 2.2(6/278) 13.7(38/278)
川崎病组 326 0(0/8) 5.5(12/218) 72.3(112/155) 8.1(26/322) 13.4(43/322) 0.3(1/320) 7.2(23/321)
χ2   3.241a 16.344 0.067 1.269 5.334 2.931a 6.890
P   0.072 <0.001 0.796 0.260 0.021 0.087 0.009
组别 例数 呼吸系统功能损伤 凝血功能异常
需呼吸支持b PaO2/FiO2<300 mmHg PT延长>3 s APTT延长>10 s INR>1.5 Fg<200 mg/L Fg>400 mg/L
脓毒症组 286 12.9(37/286) 27.6(79/286) 15.7(25/159) 20.8(33/159) 10.8(17/157) 16.8(26/155) 49.0(76/155)
川崎病组 326 0.3(1/326) 2.1(7/326) 1.9(4/216) 4.2(9/216) 1.0(2/205) 0.9(2/215) 83.3(179/215)
χ2   41.732 81.862 24.697 25.338 17.354 32.323 49.247
P   <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
组别 例数 凝血功能异常 泌尿系统功能损害
DD升高 FDP升高 PLT<150×109/L PLT<100×109/L BUN>基线1.5倍 SCr>基线1.5倍
脓毒症组 286 82.2(74/90) 74.4(67/90) 13.6(39/286) 7.7(22/286) 4.3(12/276) 4.3(12/276)
川崎病组 326 92.0(126/137) 65.4(89/136) 2.1(7/326) 0.9(3/326) 0.3(1/310) 0.3(1/310)
χ2   4.926 2.053 28.929 17.832 10.906 10.906
P   0.026 0.152 <0.001 <0.001 0.001 0.001
组别 例数 血电解质异常 Hb<90 g/L PLT>450×109/L
Na<130 mmol/L K<3.5 mmol/L K>5.5 mmol/L Ca2+<2.1 mmol/L
脓毒症组 286 10.5(29/276) 19.6(54/276) 3.3(9/276) 17.9(49/273) 21.3(61/286) 17.5(50/286)
川崎病组 326 4.8(15/311) 19.3(60/311) 0.3(1/311) 5.8(18/311) 4.6(15/326) 14.1(46/326)
χ2   6.814 0.007 5.891a 21.169 39.194 1.310
P   0.009 0.934 0.015a <0.001 <0.001 0.252
[1]
de Souza DC, Barreira ER, Faria LS. The epidemiology of sepsis in childhood[J]. Shock, 2017, 47(suppl 1): 2-5. DOI: 10.1097/SHK.0000000000000699.
[2]
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8): 801-810. DOI: 10.1001/jama.2016.0287.
[3]
陈丽妮,罗黎力,李德渊,等. 尿源性脓毒症患儿的临床特点分析[J/OL]. 中华妇幼临床医学杂志(电子版)2019, 15(3): 292-299. DOI: 10.3877/cma.j.issn.1673-5250.2019.03.009.
[4]
McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17): e927-e999. DOI: 10.1161/CIR.0000000000000484.
[5]
中华医学会儿科学分会急救学组. 儿童脓毒性休克(感染性休克)诊治专家共识(2015版)[J]. 中华儿科杂志2015, 22(11): 739-743. DOI: 10.3760/cma.j.issn.1673-4912.2015.11.001.
[6]
Murri R, Taddei E, Cauda R, et al. Use of procalcitonin as a tool for antibiotic stewardship[J]. Future Microbiol, 2019, 14: 77-79. DOI: 10.2217/fmb-2018-0326.
[7]
降钙素原急诊临床应用专家共识组. 降钙素原(PCT)急诊临床应用的专家共识[J]. 中华急诊医学杂志2012, 21(9): 8. DOI: 10.3760/cma.j.issn.1671-0282.2012.09.005.
[8]
Ae R, Abrams JY, Maddox RA, et al. Platelet count variation and risk for coronary artery abnormalities in Kawasaki disease[J]. Pediatr Infect Dis J, 2020, 39(3): 197-203. DOI: 10.1097/INF.0000000000002563
[9]
Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease[J]. Circulation, 2006, 113(22): 2606-2612. DOI: 10.1161/CIRCULATIONAHA.105.592865.
[10]
Han SB, Lee SY. Differentiating Kawasaki disease from urinary tract infection in febrile children with pyuria and C-reactive protein elevation[J]. Ital J Pediatr, 2018, 44(1): 137. DOI: 10.1186/s13052-018-0585-7.
[11]
Kakihana Y, Ito T, Nakahara M, et al. Sepsis-induced myocardial dysfunction: pathophysiology and management[J]. J Intensive Care, 2016, 4: 22. DOI: 10.1186/s13052-018-0585-7.
[12]
Cui J, Xiong J, Zhang Y, et al. Serum lactate dehydrogenase is predictive of persistent organ failure in acute pancreatitis[J]. J Crit Care, 2017, 41: 161-165. DOI: 10.1016/j.jcrc.2017.05.001
[13]
Matsubara T, Yamakawa K, Umemura Y, et al. Significance of plasma fibrinogen level and antithrombin activity in sepsis: a multicenter cohort study using a cubic spline model[J]. Thromb Res, 2019, 181: 17-23. DOI: 10.1016/j.thromres.2019.07.002.
[14]
Mitra P, Guha D, Nag SS, et al. Role of plasma fibrinogen in diagnosis and prediction of short term outcome in neonatal sepsis[J]. Indian J Hematol Blood Transfus, 2017, 33(2): 195-199. DOI: 10.1007/s12288-016-0683-x.
[15]
臧学峰,陈炜,盛博,等. 早期心脏超声联合心脏生物学标志物预测严重脓毒症的价值:一项5年的单中心回顾性研究[J]. 中华危重病急救医学201830 (4): 332-336. DOI: 10.3760/cma.j.issn.2095-4352.2018.04.009.
[16]
Vallabhajosyula S, Pruthi S, Shah S, et al. Basic and advanced echocardiographic evaluation of myocardial dysfunction in sepsis and septic shock[J]. Anaesth Intensive Care, 2018, 46(1): 13-24. DOI: 10.1177/0310057X1804600104.
[17]
王文,罗钢,张乾忠. 川崎病并发冠状动脉损害19例临床分析[J]. 中国实用儿科杂志2016, 31(11): 843-846. DOI: 10.7504/ek2016110611.
[18]
Liu X, Wang L, Shao S, et al. Sterile pyuria in Kawasaki disease: a large prospective Cohort study[J]. Front Cardiovasc Med, 2022, 9: 856144. DOI: 10.3389/fcvm.2022.856144.
[19]
Yoon SH, Kim DS, Ahn JG. Early features of Kawasaki disease with pyuria in febrile infants younger than 6 months[J]. BMC Pediatr, 2018, 18(1): 389. DOI: 10.1186/s12887-018-1362-x.
[20]
Singh S, Gupta A, Jindal AK, et al. Pulmonary presentation of Kawasaki disease: a diagnostic challenge[J]. Pediatr Pulmonol, 2018, 53(1): 103-107. DOI: 10.1002/ppul.23885.
[1] 陶宏宇, 叶菁菁, 俞劲, 杨秀珍, 钱晶晶, 徐彬, 徐玮泽, 舒强. 右心声学造影在儿童右向左分流相关疾病中的评估价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 959-965.
[2] 庄燕, 戴林峰, 张海东, 陈秋华, 聂清芳. 脓毒症患者早期生存影响因素及Cox 风险预测模型构建[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 372-378.
[3] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[4] 向韵, 卢游, 杨凡. 全氟及多氟烷基化合物暴露与儿童肥胖症相关性研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 569-574.
[5] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[6] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[7] 刘冉佳, 崔向丽, 周效竹, 曲伟, 朱志军. 儿童肝移植受者健康相关生存质量评价的荟萃分析[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 302-309.
[8] 丁荷蓓, 王珣, 陈为国. 七氟烷吸入麻醉与异丙酚静脉麻醉在儿童腹股沟斜疝手术中的应用比较[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(05): 570-574.
[9] 中华医学会器官移植学分会, 中华医学会外科学分会外科手术学学组, 中华医学会外科学分会移植学组, 华南劈离式肝移植联盟. 劈离式供肝儿童肝移植中国临床操作指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 593-601.
[10] 刘军, 丘文静, 孙方昊, 李松盈, 易述红, 傅斌生, 杨扬, 罗慧. 在体与离体劈离式肝移植在儿童肝移植中的应用比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 688-693.
[11] 张琛, 秦鸣, 董娟, 陈玉龙. 超声检查对儿童肠扭转缺血性改变的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 565-568.
[12] 陈惠英, 邱敏珊, 邵汉权. 脓毒症诱发肠黏膜屏障功能损伤的风险因素模型构建与应用效果[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 448-452.
[13] 王晓瑜, 郭群英, 牛雅萌, 赵成松. 公立儿童医院促进儿科就医均等化实践探析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 383-387.
[14] 陈晓胜, 何佳, 刘方, 吴蕊, 杨海涛, 樊晓寒. 直立倾斜试验诱发31 秒心脏停搏的植入心脏起搏器儿童一例并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 488-494.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要